mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals [electronic resource] / an interview with E. John Wherry.
Material type:
SoundSeries: Henry Stewart talksBiomedical & life sciences collection. Interviews on Covid-19: Publisher: London : Henry Stewart Talks, 2021Description: 1 online resource (1 streaming audio file (17 min.))Subject(s): Coronavirus infections -- Vaccination | COVID-19 (Disease) -- Research | COVID-19 (Disease) -- Vaccination | Messenger RNA | Vaccines | Antibodies, Neutralizing -- immunology | Antibodies, Viral -- immunology | B-Lymphocytes -- immunology | COVID-19 Vaccines -- administration & dosage | COVID-19 -- immunology | COVID-19 -- prevention & control | Immunization, Secondary | mRNA Vaccine | SARS-CoV-2 -- immunology | Spike Glycoprotein, Coronavirus -- immunology | Vaccination | Vaccines, SyntheticOnline resources: Click here to access online | Series Audio interview.
Title from title frames.
Contents: Monitoring the levels of immune cells, e.g. memory B cells, rather than levels of antibodies, as an indication of long term immune protection -- The efficacy of vaccines in previously infected vs previously uninfected individuals -- The efficacy of a single vs double dose -- The potential value of administrating a "booster" that is different from the previous administered vaccine in an individual, AKA "mixing-and-matching".
Access restricted to subscribers.
Mode of access: World Wide Web.